ÇÁ·Î±×·¥


Àλ縻 - ¹ÚÁ¾ÈÆ (´ëÇѾÏÇÐȸ ºÎȸÀå) 09:20-09:30
     
1. High-throughput and computational methods to predict response to cancer therapy 09:30-11:00
ÁÂÀå: ÇãÈÆ (¾ÆÁÖÀÇ´ë)
1) CRISPR/Cas9 gene editing platform for identifying cancer therapy ±èÅÃÈÆ (KIST)
2) Organoid for colon cancer reveals heterogenous response ±¸ÀÚ·Ï (¼­¿ïÀÇ´ë)
3) Artificial intelligence to predict immunotherapy response in cancer patients ±è»ó¿í (POSTECH)
     
Coffee Break 11:00-11:20
     
2. Clinical application of liquid biopsy beyond ctDNA 11:20-12:50
ÁÂÀå: °ø¼±¿µ (±¹¸³¾Ï¼¾ÅÍ)
1) MRD detection using ctDNA ½Å»õ¾Ï (¿¬¼¼ÀÇ´ë)
2) True Real-time Answer with CTC Evaluation (TRACE): Toward practical utility ±è¹Î¼® (DGIST)
3) The next therapeutic modality, extracellular vesicle ³²±âÈÆ (°í·ÁÀÇ´ë)
     
Lunch Break 12:50-14:00
     
3. Multidimensional immune cell analyses in immuno-oncology 14:00-15:30
ÁÂÀå: À̼ºÈ¯ (Â÷ÀÇ´ë)
1) The use of multidimensional flow cytometry for immune biomarker discovery ±Ç¹Î¼® (¾ÆÁÖÀÇ´ë)
2) Spatial multi-omics in immunology research ±èÁ¾ÈÆ (¿¬¼¼ÀÇ´ë)
3) Multiplex IHC for immune monitoring ±è»ó¿± (¼­¿ï¾Æ»êº´¿ø)
     
Coffee Break 15:30-15:50
     
4. Artificial Intelligence(AI) in drug discovery and development 15:50-17:20
ÁÂÀå: ÃÖÈ«À± (¼­¿ïÀÇ´ë)
1) Discover first-in-class drug candidates using workflow AI À±¼ÒÁ¤ (½ºÅÄ´ÙÀÓ)
2) AI in the prediction of protein structure and interaction ¼®Â÷¿Á (¼­¿ï´ë)
3) Data-driven approaches for efficient drug discovery ±è¿Ï±Ô (ÀÌÈ­¿©´ë)